Untargeted metabolomics by mass spectrometry in the form of mass over charge and intensity of ions, provides insight into the metabolic activity in a sample and is therefore essential to understand regulation and expression at the protein and transcription level.
Introduction
Metabolomics is the underlying biochemical layer of the genome, transcriptome and proteome, which reflects all the information expressed and modulated by these omics layers. Because metabolomics provides an almost direct readout of metabolic activity in the organism, metabolomics can be used to diagnose diseases from biofluids, discover new drugs and drug targets, and further precision medicine 1 .
A common method to acquire metabolomics data is mass spectrometry (MS), which records the input metabolites' mass to charge ratios (m/z). Targeted MS involves a priori metabolite selection based on a chosen compound feature, e.g. polarity, while untargeted metabolomics is performed on the input sample without pre-filtering the sample. An example of an untargeted metabolomics method is direct infusion mass spectrometry (DI-MS), which detects tens to hundreds of thousands of metabolites at single part per million (ppm) accuracy in terms of their m/z values 2 . DI-MS runtimes are in the order of one minute per sample, making it highly suitable for high-throughput applications, such as for instance in diagnostics applications. Problematically, DI-MS routinely produces over a hundred thousand unidentified m/z values, which makes user interpretation of the data exceedingly challenging [2] [3] [4] .
Before untargeted metabolomics data can be effectively utilized to answer diagnostic or research questions, m/z values need to be matched to a metabolite identity. This is a challenging task and third-party tools that aid in this process are not well developed. A particularly pressing issue is that most current MS analysis tools are limited in the number of databases that are used for metabolite identification, thus limiting the number of metabolite identities that can be matched. For instance, many MS analysis tools rely on a custom built-in database, or a fixed integrated version of a publicly available database, with no opportunity to update to the most recent version 5 . Moreover, identification of the metabolite identity is only one step in the data analysis workflow and needs to be integrated into downstream analytics, such as data normalization, statistical testing, visualization, clustering or supervised machine learning. Many of the currently available tools are only geared towards a subset of these tasks, impeding the ease-of-use and time-to-results.
Given the increasing popularity of untargeted metabolomics we sought to address these issues and enhance the strengths of the available tools and packages. The resulting software package, MetaboShiny , supports the user in performing a range of common MS data analysis steps such as normalization, statistical analysis and putative identification of m/z values. MetaboShiny is built in the interactive Shiny framework for the R programming language 6 . MetaboShiny, through our included companion package MetaDBparse developed as part of the project, supports 17 databases (Table S1 ) and is capable of searching through millions of m/z values, including metabolite variants with over twenty commonly observed adducts and isotopes (Table S2, S3 ). Additionally, users can create their own user-defined databases. Identification and statistical analysis can be performed in parallel, allowing the user to quickly find putative identities for m/z values.
MetaboShiny supports mapping m/z ratios to metabolite identities: matching the highly accurate m/z value to a database (e.g., HMDB, ChEBI, PubChem, etc.) or deducing a molecular formula based on organic chemistry and pre-defined rules such as the Seven Golden Rules that take into account ratios of oxygen, nitrogen and hydrogen atoms 3, 7 .
MetaboShiny performs downstream data analysis directly on the m/z ratios and metabolite identification occurs only on e.g. significant hits that result from the analysis. This has the advantage that the identification remains a separate entity that does not interfere with the original data and statistical analysis, so users remain aware of the untargeted nature of their data. As an alternative, the simplified 'database only' mode allows users to manually fill in a m/z of choice and search through the databases directly.
For statistical analysis, MetaboShiny integrates with the MetaboAnalystR package, the backend of the well known MetaboAnalyst, and many other R cheminformatics and statistics packages 8 . Moreover, MetaboShiny offers rapid data subsetting based on user-defined metadata, which can be used to perform analyses on subpopulations of interest, enhancing data reusability and flexible analyses. It also houses the full capabilities of the machine learning R package caret to create and analyse predictive models, as the ability of a m/z value to predict a phenotype can be of great interest in biomarker discovery.
Users can seamlessly switch between various visualizations and interactively explore tables and plots, while using various linked databases to find possible identifications for these molecules. As a result, MetaboShiny reduces the need to browse various websites with different interfaces to manually search for m/z value matches. Furthermore, the resulting high-quality and customizable figures are publication ready. Thus, researchers can devote more time to explore putative matches in depth. The installation of MetaboShiny is facilitated by Docker 9 , which pre-installs all libraries and packages, and all included databases generated with a single button click and a one-time-only run.
Results

An interactive software suite for untargeted metabolomics analysis
MetaboShiny is an R based application, wrapped in a Shiny user interface. It enables users to fluidly switch between running statistical analyses, exploring plots, tables and chemical structures, and m/z identification ( Figure 1 ). Furthermore, by summarizing the results in publication ready figures, MetaboShiny decreases the amount of time needed to get from initial data to insights.
The first step of the workflow is normalizing the data. There are various settings for normalization native to MetaboAnalyst, alongside additional options and batch correction 10, 11 . MetaboShiny moreover supports many different methods to do statistical analysis. For instance, dimensionality reduction can be achieved through Principal Component Analysis (PCA) and Partial Least Squares Discriminant Analysis (PLS-DA), and users can perform t-tests and fold-change analysis on individual m/z values. Additionally, the user can create volcano plots, heatmaps, and machine learning models supplied by the R package caret 12 . Metaboshiny also supports time-series data with options for multivariate and bivariate data( Figure 1c ).
The user can explore a specific subset of the data, based on the supplied metadata, such as diet, sex, or smoking status ( Figure 1b ). Results from all analyses can be compared through Venn diagrams, which offer hypergeometric testing to test the significance of overlapping hits and are useful for prioritizing multiple significant m/z values. By combining MetaboShiny's data subsetting functionality with Venn diagrams, users can compare the data analyses of different subsets to find specific m/z values of interest.
An important and unique feature of MetaboShiny is that it offers data interactivity through the DT and plotly R packages 13, 14 . The plotly and DT packages are instrumental in creating plots where users can click and zoom in on specific points or regions of interest or interactive tables that users can filter and sort on, and immediately continue to the m/z value identification step. Important limitations of currently available m/z identification methods are that only a single or limited set of databases is searched and that searching all available databases is very time consuming. For this reason, MetaboShiny streamlines the process of m/z identification, enabling the user to rapidly retrieve matches in a wide range of compound databases that include adducts and isotopes, according to a predetermined error margin ( Figure 1a , Figure S1 ) . Before searching for a molecular identity of an m/z value, users select the databases of interest. MetaboShiny currently supports 16 compound databases, including the Human Metabolome Database ( HMDB ), Kyoto Encyclopedia of Genes and Genomes ( KEGG ), and Chemical Entities of Biological Interest ( ChEBI ) [15] [16] [17] (Table S1 ). MetaboShiny then generates m/z values for common isotopes and adducts known to form in mass spectrometry for each compound in the database ( Figure 1a ). Compound databases are generated and stored locally by the user. MetaboShiny moreover allows users to interactively explore and filter the retrieved matches through interactive summary figures.
MetaboShiny can be downloaded and run either locally or optionally in a multi-user fashion, through the Docker platform, facilitating cross-platform use 9 . Source code is available on Github. For ease of use, we recommend Docker to avoid the complications arising from installing dependencies. 
Functionality of MetaboShiny demonstrated using a test dataset
To demonstrate the functionality of MetaboShiny, we leveraged the LC-MS dataset on urine samples from 1005 patients with and without lung cancer 18 . This work identified 4 m/z values predictive for cancer status, which were confirmed through targeted mass spectrometry. These data are publically available on MetaboLights 19 (identifier MTBLS28 ). The available peak tables for positive and negative mode offered a total of 3166 m/z values for each sample. These peak tables were reformatted to remove the retention time, which is currently not searchable in most databases and not used in MetaboShiny for compound identification (script available in supplemental). Additionally, the metadata for each sample was reformatted to fit MetaboShiny's required format. Both files were imported into MetaboShiny. The conversion script and resulting files are available in the electronic supplement. As per the original authors' protocol, an error margin of 25 parts per million (ppm) was used to perform matching 18 .
Within MetaboShiny, with a single click after entering normalization preferences, data can be log transformed and normalized based on the sum of the total sample intensity to correct for large differences in overall acquired signal during mass spectrometry detection. We further Z-transformed the data to account for differences between variable distributions. Missing values were imputed with random forest, as it was previously determined to be most accurate 20 . Any m/z values missing a signal in more than one percent of samples were excluded from further analysis. This resulted in 3141 metabolites.
Processing the data from the initial file to the point of statistical analysis takes only 5 minutes once the metadata file is in the right format (which takes approximately 10 minutes, as the MetaboLights metadata format is highly similar to the MetaboShiny format shown in table S4).
Mathé et al. initially trained a random forest model and combined the results of multiple classifiers to find compounds that were good predictors in multiple metadata groups (sex, race, and smoking status) 18 . Using MetaboShiny this analysis can be completely reproduced within only a few minutes, demonstrating the utility of the software for rapid hypothesis generation and biomarker discovery. The Random Forest classifier is amongst the 50+ machine learning algorithms included in Metaboshiny 12 . The model performs better than random classification, with an area under the curve (AUC) of 0.84. Two of the four metabolites that Mathé et al. 18 identified rank within the top 20 in terms of variable importance, with 264.1215224 m/z having the highest predictive value. Aside from m/z values, smoking status was a strong predictor for disease (ranked #2 by the Random Forest, figure 2j ).
When using MetaboShiny to search for potential identifications for the m/z value at the top of the list, a search including the HMDB uncovered creatine riboside (M+H adduct) as a putative hit ( figure 2f ). The built-in HMDB compound description page ( figure 2e) reports that this m/z feature was first discovered by Mathé et al 18 ( figure 2g ), confirming the validity of this finding. All this information can be retrieved with a few mouse clicks.
In addition to the Random Forest model, PLS-DA analysis was explored. This yielded a model that achieved significant separation between the population and lung cancer groups (p < 0.03; figure  2h ). The loading for PC1 contains the four m/z values of interest, ranked #1, #2, #12 and #15, respectively. These results indicate that the four compounds are not just significant in univariate t-tests, but also can be used to train predictive models that stratify samples by cancer status. These results could be accessed 3 minutes after the PLS-DA analysis was initiated. MetaboShiny can also be used to perform more routine analyses such as t-tests and fold-change analysis.
In depth analysis of test dataset by subsetting and intersecting analyses with MetaboShiny
MetaboShiny enables subsetting and analysis of intersecting features making it very easy for the user to subset and filter samples based on the supplied metadata. For example, as smoking is highly correlated with lung cancer risk, the dataset can be divided into three subsets based on smoking status. For each of these subsets ( present, past and never smoker ) regularized (glmnet) predictive models were built with all m/z features (Figure 3a ). The predictive importance of each m/z value in these subsets is stored and can be used to do intersectional analysis. The Venn diagram using the top 50 hits for each of these three subsets produced by MetaboShiny is presented in figure  3 and table S3 . The analysis revealed that the previously discussed compound creatine riboside ( 264.1215224 m/z, triangle in figures 2 and 3 ) is in the top 50 predictive m/z values for all three subsets, independent of smoking status (Figure 3a ). This further validates its status as top significant compound as in the results from Mathe et al 18 .
Subsequently, MetaboShiny was used to search for metabolites that only were predictive of cancer status in the group of patients that never smoked. From the top 50 predictive m/z values in total, 44 are uniquely predictive for lung cancer status in this subset, implying a larger role for them in lung cancer not influenced by smoking.
To demonstrate how MetaboShiny enables users to identify putative compounds of interest, these 44 compounds were further explored. As an example, one metabolite of interest, at 126.9069343 m/z, was identified through browsing the possible m/z identities for metabolites found in humans through the HMDB . MetaboShiny features a side panel showing differential expression for each m/z selected (figure 3b). Selecting this m/z value reveals that the t-test fails to reach significance (indicated by an absence of a star in the figure), indicating that expression in non-smoking lung cancer patients is not significantly higher compared to the healthy population. This highlights the ability of machine learning methods to prioritize m/z values using a different method than conventional statistical tests. Browsing the available identities gave insight into which compounds are interesting for further validation in targeted analyses.
To view the data from another angle, the data was analysed using the machine learning functionality of MetaboShiny. Machine learning models are capable of capturing multivariate variance that other univariate tests cannot. The full caret functionality included in MetaboShiny allows users to explore multiple machine learning models, including the random forest, LASSO, ridge regression, general linear models and many more 12 . Next, to find possible compound identifications for 126.9069343 m/z , a full search for all downloaded databases was performed (supplemental table S1). In total this returned 122 matches. After disregarding duplicates, this m/z value matches iodine and iodine-related compounds ( Figure  3c ). In this case only M-H adducts were considered, as the m/z value was registered in negative mode, and this is the most prevalent ionized form seen in this mode.
To aid the user in interpreting the results, MetaboShiny offers to do a general PubMed search in this case providing a general idea of the co-occurrence of iodine and cancer in literature. A user-specified (500 in this analysis) number of abstracts is parsed and presented in the form of a table with paper titles and either a bar chart or word cloud of the most frequently occurring terms in these abstracts (Figure 3d ). In this way, iodine was shown to be often co-mentioned in abstracts with thyroid , radiation and uptake, among others. This, although we lack metadata on how these patients were treated, may have something to do with iodine in cancer treatment. Now that the user has a quick overview of the current state of knowledge on this compound in this context, they can decide either to continue researching further leads within MetaboShiny, or move on to more focused literature research or follow-up experimentation, based on the potentially interesting leads described by the word cloud/ bar chart. 
Matching of a yet unidentified m/z 561.3432022 using Metaboshiny
To identify the unknown metabolite with m/z 561.3432022 the matching capability of MetaboShiny was leveraged .
This compound was found to be significantly elevated in lung cancer patients by the original authors 18 . While they established that the compound was conjugated with glucuronide (a process summarized in figure 4a, generally to increase solubility and thus excretability 21 ), its exact identity was not unraveled.
A new adduct, named [M+GLUC±H] , was included in the search to represent glucuronidated compounds. To do this, knowledge on which chemical groups are necessary for glucuronidation was utilized to create rules in SMARTS format ( Table S3 ) 21, 22 . Following the establishment of this new adduct, MetaboShiny's ability to flexibly calculate molecular adducts was used to implement it in the database(figure 4a). All available databases returned their possible matches for 561.3432022 m/z . When returning results, MetaboShiny offers the user a pie chart demonstrating from which databases the matches originate, and which adducts were mainly found as possible identities. Filtering out everything that was not a glucuronidated adduct through the interactive pie chart in figure 4a resulted in multiple main-isotope matches, which can be considered as possible matches for 561.3432022 m/z (figure 4b). When creating new adducts one must consider if this is chemically valid. This is achieved by using the integrated molecular structure visualization (figure 4c) to estimate if the required groups for glucuronidation are present in the candidate molecule, enabled by the rcdk package 23 . Browsing through these results revealed N-palmitoyl glutamine. The integrated PubChem search (figure 4d) furthermore uncovered a paper demonstrating the potential of a very closely related compound, N-palmitoyl glutamic acid, to differentiate pancreatic cancer from pancreatitis using LC-MS metabolomics 24 . Although this m/z value is found in a different setting, the fact that is is found in the context of LC-MS metabolomics in cancer detection makes this a strong lead to investigate further. Taken together, this demonstrates the power of MetaboShiny to achieve rapid hypothesis generation, which can be followed up with additional experiments.
Comparison of Metaboshiny with existing tools
Many tools perform specific roles in metabolomic analyses, such as pathway analysis or compound identification. MetaboShiny performs multiple analysis steps and integrates many smaller tools into one toolbox. MetaboShiny should therefore be compared to toolboxes with a similar multi-level approach 5 . In this section we discuss four existing platforms and compare them to MetaboShiny. SECIMtools (SouthEast Center for Integrated Metabolomics) is a suite of metabolomics tools that can be run either as a standalone or on the Galaxy platform for bioinformatics 25 . It specializes in LC-MS data processing and offers multiple statistical analyses (heatmaps, PCA, PLS-DA, clustering, ANOVA), machine learning algorithms (random forest and LASSO), and, accordingly, many visualizations to show the results 26 . MetaboShiny also offers these analyses and further expands upon them, with over seventy machine learning methods available through the caret package. Additionally, although SECIMtools offers more visualizations, MetaboShiny, allows the user to interactively click on the plots to immediately continue analysis and identification, which aids in quick exploration of multiple m/z values as illustrated below with the test dataset. SECIMtools does not offer identification of m/z values, meaning that users have to manually identify their features of interest.
MetaboScape is Bruker's commercial platform for untargeted (LC-MS) metabolomics. It, like MetaboShiny, supports data integration, normalization, statistical analysis and identification 27 . Its identification heavily leans on molecular formula prediction, which is available in MetaboShiny as well. MetaboScape offers many visualizations, but users cannot directly interact with them, but need to pre-label metabolites of interest that are then highlighted in further plots, offering some, but limited, interactivity. MetaboScape does not allow the user to pick databases for identification, nor does it allow users to add their own database. Specialized in LC-MS data, it is not built to work with DI-MS type dataset which contains only m/z values.
Netome , developed by the Broad Institute of MIT and Harvard offers many tools, separately in Python or R, or together in the netome platform. It offers clustering and visualization, alongside access to and tweaking of the raw data 28 . As raw data format and thus necessary processing differs greatly based on the platform used to obtain it, MetaboShiny requires the data to be in peak table format (Table S5 ). Raw data processing can be performed using specialized packages such as msconvert for conversion and the broadly used xcms package for peak calling and aligning. MetaboAnalyst is a webserver with an extensive host of statistical analyses 29 . Users are limited to 5000 metabolites, however, DI-MS usually generates up to hundreds of thousands of m/z values. MetaboShiny employs the MetaboAnalystR package 8 for statistical analyses, while extending its functionality with machine learning and more extensive interaction with result tables and plots.
Additionally, MetaboAnalyst offers limited identification capabilities, most of which are connected to pathway analyses, where m/z notation is replaced by a putative identity. This identity is done by matching the m/z to the HMDB 16 . MetaboShiny gives the user more control over this process, and allows the user to keep track of which m/z connects to which putative identity. An overview of the above comparisons can be seen in Table 1 . 
Performance quantification of MetaboShiny
Lastly, to quantify MetaboShiny's speed, a quantitative analysis was performed on MetaboShiny's speed performance. MetaboAnalyst has an upper limit of 5000 compounds for each analysis, in contrast to MetaboShiny, where dataset size is limited only by memory and processor speed of the user's machine. This is the advantage of it being run locally through either Docker or R natively. We recorded the time of a match for a single m/z value in databases of varying sizes. This is particularly relevant as MetaboShiny allows the user to expand their m/z database by adding more data sources which puts a substantial burden on the matching procedure. For an informative comparison, we created 300 databases spanning the range of real world database sizes. For each of these database sizes, a random pool of 100 m/z values, evenly distributed over the 60 -600 m/z range were used individually to perform a match search.
Although searching larger databases takes a longer time, figure 5 reveals a connection between time and the number of matches found for each m/z value. M/z values with more matches in the database will take a bit longer to return, as MetaboShiny fetches additional information (description, molecular formula, name) when a match is found. Regardless of this, one search even at the current maximum database size (if the user downloads and builds all currently included databases), does not exceed 0.8 seconds for a single search, often staying below half a second ( Figure 5b ) . 
Discussion
In this paper we introduced MetaboShiny, an R-based and RShiny-based interactive metabolomic analysis and identification tool. It was developed to facilitate metabolomics biomarker discovery, focused on untargeted metabolomics data. MetaboShiny offers a way to integrate large metabolomics datasets with (extensive) metadata, normalize data and perform a broad range of statistical analyses to find potential biomarkers. Once it uncovers m/z values of significance, either through a single analysis or through intersecting the results of multiple analyses, an extensive identification module currently covering 16 databases guides the user towards a putative identity of their compounds of interest, without having to go through multiple databases and websites manually.
We have demonstrated the power of MetaboShiny by reanalyzing the dataset from Mathé et al 18 . Using MetaboShiny, within minutes we were able to validate their number one novel compound of interest, creatine riboside, and show that the other three compounds were all highly ranked in statistical tests. Furthermore, we could perform variations on their Venn diagram analysis combining subset analyses of smokers, non-smokers and former smokers. With integrated subsetting tools, broad-spectrum multi-database-and PubChem searches and various customizable methods of interactive visualization we were able to discover two bona-fide candidates with substantial orthogonal evidence to consider for validation using targeted mass spectrometry. This demonstrates MetaboShiny's ability to guide the user from a peak table and metadata, to biomarkers of interest and their putative identity.
Although we did not find all four compounds at the same significance level as in the primary publication, this is to be expected, since the normalization method and statistical test parameters used here are likely different. We also did not have access to the full metadata including disease stage, which could have been used to reproduce their results more accurately.
Putative identities of m/z values will still require validation through lab work, as untargeted metabolomics only offers m/z values to work with. By prioritizing compounds based on their isotope and adduct status, alongside using database compound descriptions to prioritize compounds based on what is biologically known about them, users can proceed to LC-MS and MS/MS to validate the identity of their marker of interest. Prioritization can potentially be further optimized resulting in fewer potential identities by implementing deep learning using an adapted chemical reaction prediction framework 31 .
Like most software tools, MetaboShiny requires data preprocessing. Examples of metadata tables and peak tables compatible with MetaboShiny are given in supplementary table 5 and 6 for metadata and peak data respectively. The metadata format was developed with an in-house data steward to be easy to use. The peak table is required to be in wide format. MetaboShiny does not process raw data output from each type of mass spectrometer and it needs to be processed first.
Further plans include further refining in silico compound identification and prioritization and expanding the amount of available databases, further enhancing the ability of MetaboShiny to streamline data integration, statistical analysis and, most of all, compound identity prioritization.
Methods
Databases
The most recent release of the database is either downloaded from the creator or through querying the creator's web application programming interface (API). Each database only needs to be downloaded once but can be updated by re-downloading the latest version of the database. The databases contain the name, molecular formula, charge, description, and if available, structure in SMILES format 32 . Currently, 45 adduct variants, 21 in positive ion mode and 24 in negative ion mode, are calculated for each molecular formula and its isotopes ( Table S2 ). Users can add and remove adducts through the settings panel.
In terms of adduct creation, the structure in SMILES can be used to pre-filter which compounds can form which adducts. Users can supply a SMARTS string that finds possible chemical sites needed for the adduct to be created, also called adduct rules 22, 32 . If such a rule is not supplied, or no SMILES are available for a compound, the structure is not checked and adduct possibility is based on molecular formula only (presence and absence of necessary atoms for the reaction).
Metadata
When creating a MetaboShiny project, users upload their peak table (in either .CSV or .SQLITE format) and metadata (in .XLS(X) or .CSV format). The general structure of these tables is visualized under the boxes in the directional graph in Figure 1b . Examples are provided in Table  S4 -S5 . The metadata table requires a date of measurement, sample identifier, unique individual identifier and experimental group. The user can add more data if so desired at will, including other specifics of the experiment such as supplement dosages, diet types or age. All of these features can be used later in subsetting and machine learning. The metadata is included by manipulating the formed MetaboAnalystR project ( mSet ) post-normalization within R and can be used to subset data.
Data storage
M/z error margins are stored in SQLITE in an RTree structure, which allows for fast range searches 33 . MetaboShiny uses the mean m/z and parts per million (ppm) error margin to create an m/z range table (min -max m/z allowed to match), which is later used to quickly find matches in the downloaded compound databases. For every sample, the intensity of every m/z peak is stored, alongside the ionization mode it was found in (positive or negative). The ionization mode is important when matching specific adducts, because some adducts are only formed in either negative or positive mode.
The compound databases are also stored in SQLITE. The source database is downloaded from the host and is parsed into a format containing the name, description, formula, charge and structure of each compound using the included MetaDBparse companion package. These reformatted 'base' databases are saved separately per source database as separate files. The extended database containing all adducts and isotopes for each molecular structure has a different structure to avoid redundant calculation of adducts and isotopes -it does not use the compound descriptions and names but only hosts the information necessary to calculate m/z values, which is molecular formula, structure and charge. The base and extended databases are joined together when performing identification to provide all the information necessary for the user. The differences in data structure between the base and extended tables are visualised in Figure 1a .
Normalization
MetaboAnalystR requires a .CSV file with a specific formatting 8 . For the majority of the normalization options users can refer to the MetaboAnalystR package. MetaboShiny also implements such random forest missing value imputation as additional option 10 . Batch correction is based on the batch included in the metadata file, with or without quality control (QC) samples, using either the ComBat or BatchCorrMetabolomics packages depending on the presence of these QC samples 11, 34 .
Visualization
MetaboShiny mostly relies on the ggplot2 package for data visualization. All of the commonly available color palettes and plot styles from ggplot2 are available 35 . MetaboShiny features 2d and 3d scatter plots for dimension reduction, line plots (used for temporal analysis and machine learning plots), box/violin/beeswarm plots, heatmaps, pie charts and venn diagrams.
All these plots are interactive because of the DT and plotly R packages 13, 14 . These packages are instrumental in creating plots where users can click on specific points of interest or interactive tables that users can filter and sort on, and immediately continue to the m/z value identification step. This interactivity is particularly useful when exploring heatmaps and volcano plots, where many methods use labels for the hundreds of points or rows. This reduces clutter and users can zoom in on selected areas and explore them at will ( Figure S8 ).
Machine learning
Although MetaboAnalystR natively supports several machine learning methods, MetaboShiny uses the caret package 12 , which is currently the most extensive machine learning package available for R. It allows users to apply almost a hundred different methods with manually tunable parameters, to maximise flexibility. In terms of results, MetaboShiny offers a summary receiver operating characteristic (ROC) curve, the area under the curve (AUC) and a separate bar chart with variable importance for each m/z and metadata value. These are all interactive, and users can view the weight of each predictor once clicking on a specific ROC curve.
For the analysis discussed in this work, MetaboShiny built 20 random forest models for the analysis of the whole dataset, using parameters mtry = 2 and ntree = 500 .
Identification
Every time the user selects an m/z value from a plot or table, it is registered, and this ' current m/z value' is displayed on the search tab on the sidebar that remains visible during statistical analysis. Once the user has selected adducts and databases, a search can be carried out. Since the m/z value of interest is linked to an m/z range table, which takes the ppm error margin into account, MetaboShiny will retrieve the information associated with all compounds that fall within this m/z range within all selected databases. Results are displayed within a table with multiple pages in the sidebar, alongside a figure summarizing the words used in the descriptions, and two figures summarizing which adducts and which databases are represented in the results. To increase insights, users can choose to search in a user-specified amount of PubMed abstracts and find the most used words in these abstracts. They can also view all of the titles of these papers.
An additional functionality includes predicting possible chemical formulas based on m/z value and predetermined rules, utilizing some the Seven Golden Rules 7 (excluding the rules that use presence in existing databases). Using either the elements CHO, CHNO, CHNOP and CHNOPS as possible elements, possible formulas adding up to the m/z in question are generated. These are then filtered according to Golden Rules dictating which ratios of elements to one another are most likely. These rules were acquired from the Visual Basic script offered by the Fiehn lab 7 . Users can choose whether to use these rules or not. Search functionality is provided by our MetaDBparse package which is included in the docker file.
Availability
At time of publication, MetaboShiny will be available on Docker Hub under the jcwolthuis/metaboshiny repository. The source code is available on GitHub in the UMCUGenetics/MetaboShiny repository. If building from source, administrator rights are needed to install the necessary libraries. The MetaDBparse package containing all the search and compound-db specific functionality without the shiny user interface is available from the UMCUGenetics/MetaDBparse repository. 
Supplemental Materials
309
Blood Exposome Database
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